The problems of treating adolescent asthma: what are the alternatives to inhaled therapy?

National Heart Lung and Blood Institute, 1995, Global Initiative for Asthma Kaur, 1998, Prevalence of asthma symptoms, diagnosis, and treatment in 12–14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK), Br Med J, 316, 118, 10.1136/bmj.316.7125.118 Ford, 1988, Asthma: does an accurate diagnosis influence school attendance and performance?, Aust New Zealand J Med, 18, 134 1998, The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee, Eur Respir J, 12, 315, 10.1183/09031936.98.12020315 1998, The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee, Lancet, 351, 1225, 10.1016/S0140-6736(97)07302-9 Price, 1997, The transition of management from childhood to adolescence, Eur Respir J, 7, 19 Office of Population Census Surveys, 1990, Mortality Statistics 1997 Siersted, 1998, Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study, Br Med J, 316, 651, 10.1136/bmj.316.7132.651 1997, Attitudes towards asthma Gibson, 1995, Asthma knowledge, attitudes, and quality of life in adolescents, Arch Dis Child, 73, 321, 10.1136/adc.73.4.321 Balfour-Lynn, 1986, Growth and childhood asthma, Arch Dis Child, 61, 1049, 10.1136/adc.61.11.1049 Verberne, 1997, One year treatment with salmeterol compared with beclomethasone in children, Am J Respir Crit Care Med, 156, 688, 10.1164/ajrccm.156.3.9611067 Vila, 1998, Asthma severity and psychopathology in a tertiary care department for children and adolescents, Eur Child Adolesc Psychiatry, 7, 137, 10.1007/s007870050059 Silverglade, 1993, Irrational beliefs and emotionality in adolescents with and without bronchial asthma, J Gen Psychology, 121, 199, 10.1080/00221309.1994.9921196 Bussing, 1995, Prevalence of behaviour problems in US children with asthma, Arch Pediatr Adolesc Med, 149, 565, 10.1001/archpedi.1995.02170180095018 Brook, 1993, Attitudes of asthmatic and nonasthmatic children towards cigarettes and smoking, Clin Paediatr, 32, 642, 10.1177/000992289303201101 Coughlin, 1988, Sport and the asthmatic child: a study of exercise-induced asthma and the resultant handicap, JR Coll Gen Pract, 38, 253 Lenney, 1994, The burden of paediatric asthma, Eur Respir Rev, 4, 49 Cochrane, 1996, Compliance in patients with asthma, Drugs, 52, 12, 10.2165/00003495-199600526-00004 Dompeling, 1992, Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique, Fam Pract, 9, 161, 10.1093/fampra/9.2.161 Rand, 1992, Metered dose inhaler adherence in a clinical trial, Am Rev Respir Dis, 146, 1559, 10.1164/ajrccm/146.6.1559 Bosley, 1994, Patient compliance with inhaled medication: does combining betaagonists with corticosteroids improve compliance?, Eur Respir J, 7, 504, 10.1183/09031936.94.07030504 Cutts, 1992, Measuring compliance with inhaled medication in asthma, Arch Dis Child, 67, 332, 10.1136/adc.67.3.332 Milgrom, 1996, Non-compliance and treatment failure in children with asthma, J Allergy Clin Immunol, 98, 1051, 10.1016/S0091-6749(96)80190-4 Rao, 1999, Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone, Eur Respir J, 13, 87, 10.1183/09031936.99.13108799 Barnes, 1998, Efficacy and safety of inhaled corticosteroids, Am J Respir Crit Care Med, 157, S1, 10.1164/ajrccm.157.3.157315 Gregson, 1998, Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone diproprionate, Osteoporosis Int, 8, 418, 10.1007/s001980050085 Greening, 1994, Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroids, Lancet, 344, 219, 10.1016/S0140-6736(94)92996-3 Pauwels, 1997, Effect on inhaled formoterol and budesonide on exacerbations of asthma, N Engl J Med, 337, 1405, 10.1056/NEJM199711133372001 Woolcock, 1996, Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids, Am J Respir Crit Care Med, 153, 1481, 10.1164/ajrccm.153.5.8630590 Evans, 1997, A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma, N Engl J Med, 337, 1412, 10.1056/NEJM199711133372002 Lloyd, 1998, Education and adherence to therapy in a clinical setting, Eur Respir Rev, 58, 333 Lenney, 1996, The development of future management plans in children with asthma, Eur Respir Rev, 6, 208 Townsend, 1991, Adolescent smokers seen in general practice: health, lifestyle, physical measurements, and response to antismoking advice, Br Med J, 303, 947, 10.1136/bmj.303.6808.947 Greenberg, 1984, Overview of patient compliance with medication dosing: a literature review, Clin Ther, 5, 592 Weinberg, 1998, Assessment of preference for oral zafirlukast vs inhaled belcomethasone in adolescent asthmatics, Eur Respir J, 12, 365 Pauwels, 1989, New aspects of the therapeutic potential of theophylline in asthma, J Allergy Clin Immunol, 83, 548, 10.1016/0091-6749(89)90036-5 Kidney, 1995, Immunomodulation by theophylline in asthma, Am J Respir Crit Care Med, 151, 1907, 10.1164/ajrccm.151.6.7767539 Sullivan, 1994, Anti-inflammatory effects of low-dose oral theophylline in atopic asthma, Lancet, 343, 1006, 10.1016/S0140-6736(94)90127-9 Horiguchi, 1999, Suppression of airway inflammation by theophylline in adult bronchial asthma, Respiration, 66, 124, 10.1159/000029353 Kelloway, 1994, Comparison of patient's compliance with prescribed oral and inhaled asthma medications, Arch Intern Med, 154, 1349, 10.1001/archinte.1994.00420120066007 Barnes, 1997, Current therapies for asthma: promise and limitations, Chest, 111, 17S, 10.1378/chest.111.2_Supplement.17S Hoshino, 1997, Effects of ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma, Allergy, 52, 814, 10.1111/j.1398-9995.1997.tb02152.x Loftus, 1987, Long-term, placebo-controlled trial of ketotifen in the management of pre-school children with asthma, J Allergy Clin Immunol, 79, 350, 10.1016/0091-6749(87)90154-0 Drazen, 1999, Treatment of asthma with drugs modifying the leukotriene pathway, N Engl J Med, 340, 197, 10.1056/NEJM199901213400306 Hay, 1997, Pharmacology of leukotriene receptor antagonists: more than inhibitors of bronchoconstriction, Chest, 111, 35S, 10.1378/chest.111.2_Supplement.35S Laitinen, 1993, Leukotriene E4 and granulocytic infiltration into asthmatic airways, Lancet, 341, 989, 10.1016/0140-6736(93)91073-U Liu, 1996, Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial, J Allergy Clin Immunol, 98, 859, 10.1016/S0091-6749(96)80002-9 Meltzer, 1996, Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor, Am J Respir Crit Care Med, 153, 931, 10.1164/ajrccm.153.3.8630575 Dykewicz, 1998, Recent findings in asthma likely to impact patient care, Comp Ther, 24, 187 Taylor, 1991, Effect of cysteinyl-leukotriene antagonist ICI 204,219 on allergen-induced bronchoconstriction and airway hyperactivity in atopic subjects, Lancet, 337, 690, 10.1016/0140-6736(91)90277-V Calhoun, 1998, Effect of zafirlukast (Accolate) on cellular mediators of inflammation, J Respir Crit Care, 157, 1381, 10.1164/ajrccm.157.5.9609014 Reiss, 1998, Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma, Arch Intern Med, 158, 1213, 10.1001/archinte.158.11.1213 Nathan, 1998, Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction, J Allergy Clin Immunol, 102, 935, 10.1016/S0091-6749(98)70331-8 Spector, 1994, Effects of 6 weeks of therapy with oral doses of ICI 204, 219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma, Am J Respir Crit Care Med, 150, 618, 10.1164/ajrccm.150.3.8087328 Fish, 1997, Zafirlukast for symptomatic mild to moderate asthma: a 13-week multicenter study, Clin Ther, 19, 675, 10.1016/S0149-2918(97)80092-6 Tashkin, 1999, An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses, J Allergy Clin Immunol, 103, 246, 10.1016/S0091-6749(99)70498-7 Kemp, 1999, Therapeutic effect of zafirlukast as monotherapy in steroid-naïve patients with severe persistent asthma, Chest, 115, 336, 10.1378/chest.115.2.336 Hassal, 1998, Zafirlukast (Accolat™) reduces the need for oral steroid bursts, Am J Respir Crit Care Med, 157, A411 Malmstrom, 1999, Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma, Ann Intern Med, 130, 487, 10.7326/0003-4819-130-6-199903160-00005 Ringdal, 1997, A comparison of patient preference for treatment with oral zafirlukast or inhaled beclomethasone, Eur Respir J, 10, 437s Chung, 1997, Compliance with an oral asthma treatment: electronic monitoring of twice daily dosing with zafirlukast, Allergy Clin Immunol Int, 9, 241 Suissa, 1997, Effectiveness of the leukotriene receptor antagonist zafirlukast for mild to moderate asthma, Ann Intern Med, 126, 177, 10.7326/0003-4819-126-3-199702010-00001 Pearlman, 1999, The leukotriene D4-receptor antagonist, zafirlukast, attenuates exercise-induced bronchoconstriction in children, J Pediatr, 134, 273, 10.1016/S0022-3476(99)70449-X Kemp, 1998, Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year old children with asthma, J Pediatr, 133, 424, 10.1016/S0022-3476(98)70281-1